Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Breast carcinoma
Breast carcinoma by gene expression profile
A header term that includes the following breast carcinoma subtypes determined by gene expression profiling: luminal A breast carcinoma, luminal B breast carcinoma, HER2 positive breast carcinoma, basal-like breast carcinoma, triple-negative breast carcinoma, and normal breast-like subtype of breast carcinoma.
-
Her2-receptor negative breast cancer 241 trials · 1,358 incl. sub-types Sub-types →
-
Estrogen-receptor positive breast cancer 183 trials · 772 incl. sub-types Sub-types →
-
Estrogen-receptor negative breast cancer 24 trials · 705 incl. sub-types Sub-types →
-
Progesterone-receptor negative breast cancer 3 trials · 703 incl. sub-types Sub-types →
-
Progesterone-receptor positive breast cancer 16 trials · 659 incl. sub-types Sub-types →
-
HER2 positive breast carcinoma 407 trials · 426 incl. sub-types Sub-types →
-
Breast tumor luminal A or B 6 trials · 15 incl. sub-types Sub-types →